China Dementia and Movement Disorder Treatment Market Report & Forecast 2021-2027

China Dementia and Movement Disorder Treatment Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Dementia and Movement Disorder Treatment Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Dementia and Movement Disorder Treatment Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Dementia and Movement Disorder Treatment Overall Market Size
2.1 China Dementia and Movement Disorder Treatment Market Size: 2021 VS 2027
2.2 China Dementia and Movement Disorder Treatment Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Dementia and Movement Disorder Treatment Players in China Market
3.2 Top China Dementia and Movement Disorder Treatment Companies Ranked by Revenue
3.3 China Dementia and Movement Disorder Treatment Revenue by Companies
3.4 Top 3 and Top 5 Dementia and Movement Disorder Treatment Companies in China Market, by Revenue in 2020
3.5 Companies Dementia and Movement Disorder Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dementia and Movement Disorder Treatment Players in China Market
3.6.1 List of Tier 1 Dementia and Movement Disorder Treatment Companies in China
3.6.2 List of Tier 2 and Tier 3 Dementia and Movement Disorder Treatment Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Dementia and Movement Disorder Treatment Market Size Markets, 2021 & 2027
4.1.2 MAO Inhibitors (Monoamine Oxidase)
4.1.3 AChE Inhibitors (Acetylcholinesterase)
4.1.4 Glutamate Inhibitors
4.2 By Type - China Dementia and Movement Disorder Treatment Revenue & Forecasts
4.2.1 By Type - China Dementia and Movement Disorder Treatment Revenue, 2016-2021
4.2.2 By Type - China Dementia and Movement Disorder Treatment Revenue, 2022-2027
4.2.3 By Type - China Dementia and Movement Disorder Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Dementia and Movement Disorder Treatment Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - China Dementia and Movement Disorder Treatment Revenue & Forecasts
5.2.1 By Application - China Dementia and Movement Disorder Treatment Revenue, 2016-2021
5.2.2 By Application - China Dementia and Movement Disorder Treatment Revenue, 2022-2027
5.2.3 By Application - China Dementia and Movement Disorder Treatment Revenue Market Share, 2016-2027
6 Dementia and Movement Disorder Treatment Companies Profiles
6.1 Pfizer
6.1.1 Pfizer Company Details
6.1.2 Pfizer Business Overview
6.1.3 Pfizer Dementia and Movement Disorder Treatment Introduction
6.1.4 Pfizer Dementia and Movement Disorder Treatment Revenue in China Market (2016-2021)
6.1.5 Pfizer Recent Developments
6.2 Novartis
6.2.1 Novartis Company Details
6.2.2 Novartis Business Overview
6.2.3 Novartis Dementia and Movement Disorder Treatment Introduction
6.2.4 Novartis Dementia and Movement Disorder Treatment Revenue in China Market (2016-2021)
6.2.5 Novartis Recent Developments
6.3 Roche
6.3.1 Roche Company Details
6.3.2 Roche Business Overview
6.3.3 Roche Dementia and Movement Disorder Treatment Introduction
6.3.4 Roche Dementia and Movement Disorder Treatment Revenue in China Market (2016-2021)
6.3.5 Roche Recent Developments
6.4 Teva
6.4.1 Teva Company Details
6.4.2 Teva Business Overview
6.4.3 Teva Dementia and Movement Disorder Treatment Introduction
6.4.4 Teva Dementia and Movement Disorder Treatment Revenue in China Market (2016-2021)
6.4.5 Teva Recent Developments
6.5 Amgen
6.5.1 Amgen Company Details
6.5.2 Amgen Business Overview
6.5.3 Amgen Dementia and Movement Disorder Treatment Introduction
6.5.4 Amgen Dementia and Movement Disorder Treatment Revenue in China Market (2016-2021)
6.5.5 Amgen Recent Developments
6.6 UCB
6.6.1 UCB Company Details
6.6.2 UCB Business Overview
6.6.3 UCB Dementia and Movement Disorder Treatment Introduction
6.6.4 UCB Dementia and Movement Disorder Treatment Revenue in China Market (2016-2021)
6.6.5 UCB Recent Developments
6.7 H. Lundbeck
6.7.1 H. Lundbeck Company Details
6.7.2 H. Lundbeck Business Overview
6.7.3 H. Lundbeck Dementia and Movement Disorder Treatment Introduction
6.7.4 H. Lundbeck Dementia and Movement Disorder Treatment Revenue in China Market (2016-2021)
6.7.5 H. Lundbeck Recent Developments
6.8 Eli Lilly
6.8.1 Eli Lilly Company Details
6.8.2 Eli Lilly Business Overview
6.8.3 Eli Lilly Dementia and Movement Disorder Treatment Introduction
6.8.4 Eli Lilly Dementia and Movement Disorder Treatment Revenue in China Market (2016-2021)
6.8.5 Eli Lilly Recent Developments
6.9 Allergan
6.9.1 Allergan Company Details
6.9.2 Allergan Business Overview
6.9.3 Allergan Dementia and Movement Disorder Treatment Introduction
6.9.4 Allergan Dementia and Movement Disorder Treatment Revenue in China Market (2016-2021)
6.9.5 Allergan Recent Developments
6.10 Eisai
6.10.1 Eisai Company Details
6.10.2 Eisai Business Overview
6.10.3 Eisai Dementia and Movement Disorder Treatment Introduction
6.10.4 Eisai Dementia and Movement Disorder Treatment Revenue in China Market (2016-2021)
6.10.5 Eisai Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Dementia and Movement Disorder Treatment Market Opportunities & Trends in China Market
Table 2. Dementia and Movement Disorder Treatment Market Drivers in China Market
Table 3. Dementia and Movement Disorder Treatment Market Restraints in China Market
Table 4. Key Players of Dementia and Movement Disorder Treatment in China Market
Table 5. Top Dementia and Movement Disorder Treatment Players in China Market, Ranking by Revenue (2019)
Table 6. China Dementia and Movement Disorder Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Dementia and Movement Disorder Treatment Revenue Share by Companies, 2016-2021
Table 8. Companies Dementia and Movement Disorder Treatment Product Type
Table 9. List of Tier 1 Dementia and Movement Disorder Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Dementia and Movement Disorder Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Dementia and Movement Disorder Treatment Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Dementia and Movement Disorder Treatment Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Dementia and Movement Disorder Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Dementia and Movement Disorder Treatment Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Dementia and Movement Disorder Treatment Revenue (US$, Mn), 2022-2027
Table 17. Pfizer Company Details
Table 18. Pfizer Business Overview
Table 19. Pfizer Dementia and Movement Disorder Treatment Product
Table 20. Pfizer Dementia and Movement Disorder Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Pfizer Recent Developments
Table 22. Novartis Company Details
Table 23. Novartis Business Overview
Table 24. Novartis Dementia and Movement Disorder Treatment Product
Table 25. Novartis Dementia and Movement Disorder Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Novartis Recent Developments
Table 27. Roche Company Details
Table 28. Roche Business Overview
Table 29. Roche Dementia and Movement Disorder Treatment Product
Table 30. Roche Dementia and Movement Disorder Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Roche Recent Developments
Table 32. Teva Company Details
Table 33. Teva Business Overview
Table 34. Teva Dementia and Movement Disorder Treatment Product
Table 35. Teva Dementia and Movement Disorder Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Teva Recent Developments
Table 37. Amgen Company Details
Table 38. Amgen Business Overview
Table 39. Amgen Dementia and Movement Disorder Treatment Product
Table 40. Amgen Dementia and Movement Disorder Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Amgen Recent Developments
Table 42. UCB Company Details
Table 43. UCB Business Overview
Table 44. UCB Dementia and Movement Disorder Treatment Product
Table 45. UCB Dementia and Movement Disorder Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 46. UCB Recent Developments
Table 47. H. Lundbeck Company Details
Table 48. H. Lundbeck Business Overview
Table 49. H. Lundbeck Dementia and Movement Disorder Treatment Product
Table 50. H. Lundbeck Dementia and Movement Disorder Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 51. H. Lundbeck Recent Developments
Table 52. Eli Lilly Company Details
Table 53. Eli Lilly Business Overview
Table 54. Eli Lilly Dementia and Movement Disorder Treatment Product
Table 55. Eli Lilly Dementia and Movement Disorder Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Eli Lilly Recent Developments
Table 57. Allergan Company Details
Table 58. Allergan Business Overview
Table 59. Allergan Dementia and Movement Disorder Treatment Product
Table 60. Allergan Dementia and Movement Disorder Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Allergan Recent Developments
Table 62. Eisai Company Details
Table 63. Eisai Business Overview
Table 64. Eisai Dementia and Movement Disorder Treatment Product
Table 65. Eisai Dementia and Movement Disorder Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 66. Eisai Recent Developments
List of Figures
Figure 1. Dementia and Movement Disorder Treatment Segment by Type
Figure 2. Dementia and Movement Disorder Treatment Segment by Application
Figure 3. China Dementia and Movement Disorder Treatment Market Overview: 2020
Figure 4. China Dementia and Movement Disorder Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Dementia and Movement Disorder Treatment Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Dementia and Movement Disorder Treatment Revenue in 2020
Figure 7. By Type - China Dementia and Movement Disorder Treatment Revenue Market Share, 2016-2027
Figure 8. By Application - China Dementia and Movement Disorder Treatment Revenue Market Share, 2016-2027
Figure 9. Pfizer Dementia and Movement Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Novartis Dementia and Movement Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Roche Dementia and Movement Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Teva Dementia and Movement Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Amgen Dementia and Movement Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. UCB Dementia and Movement Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. H. Lundbeck Dementia and Movement Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Eli Lilly Dementia and Movement Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Allergan Dementia and Movement Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Eisai Dementia and Movement Disorder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Alzheimer's Disease Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Alzheimer's Disease Drug market size was valued at US$ 3539.3 million in 2023. With growing demand in downstream market, the Alzheimer's Disease Drug is forecast to a readjusted size of US$ 3943.3 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Alzheimer's Disease Drug market. Alzheimer's Disease Drug are expected to show stable growth in the future m......

Alzheimer's Drugs - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 97

The global Alzheimer's Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Alzheimer's Drugs in various end use industries. The expanding demands from the Under 65 Years Old and 65 and Above 65 Years Old, are propelling Alzheimer's Drugs market. Acetylcholinesterase (AChE) Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by t......

Alzheimer Disease Drugs Industry Forecasts - China Focus

Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 111

This study focuses on China's Alzheimer Disease Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and servi......

Alzheimer Disease Drugs Companies in China

Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 74

This study focuses on China's Alzheimer Disease Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumpt......

Alzheimer Disease Drugs Markets in China

Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 239

China's demand for Alzheimer Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacit......

Global Alzheimer's Disease Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 12-Sep-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Alzheimer's Disease Drug market: According to our latest research, the global Alzheimer's Disease Drug market looks promising in the next 5 years. As of 2022, the global Alzheimer's Disease Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Alzheimer's disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills and,......

Global Dementia and Movement Disorder Treatment Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 110

Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality changes, difficulty in performing activities, loss of memory, and aphasia. Market Analysis and Insights: Global Dementia and Movement Disorder Treatment Market The global Dementia and Movement......

Global Nicergoline Market Insights, Forecast to 2029

Published: 04-Jul-2023        Price: US 4900 Onwards        Pages: 112

The global Nicergoline market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Nicergoline is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for Nicergoline is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR......

Global Oxiracetam Market Research Report 2023

Published: 21-Apr-2023        Price: US 2900 Onwards        Pages: 69

Highlights The global Oxiracetam market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Oxiracetam is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. Asia-Pacific ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs